Moran Susan
SEC insider (Form 3/4/5 filer). CIK 0001835225. Director at CRESCENT BIOPHARMA, INC. (CBIO) and 2 other issuers. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 2, 2026. Located in CARLSBAD, CA.
Companies Moran Susan has filed insider reports for
- CRESCENT BIOPHARMA, INC. (CBIO): Director
- Tyra Biosciences, Inc. (TYRA): Director
- BioAtla, Inc. (BCAB): Director
Moran Susan
CIK: 0001835225
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 2, 2026CBIO
CRESCENT BIOPHARMA, INC.
AwardDirectStock Option (Right to Buy)
11.1K shares- - May 28, 2026TYRA
Tyra Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
13.2K shares- - Jun 23, 2025CBIO
GLYCOMIMETICS INC
AwardDirectStock Option (Right to Buy)
9K shares- - Jun 18, 2025BCAB
BioAtla, Inc.
AwardDirect23.5K shares- - May 29, 2025TYRA
Tyra Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
22.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 2, 2026 |  CBIO CRESCENT BIOPHARMA, INC. | Award Stock Option (Right to Buy) | 11,050 | - | - | Direct |
| May 28, 2026 |  TYRA Tyra Biosciences, Inc. | Award Stock Option (Right to Buy) | 13,160 | - | - | Direct |
| Jun 23, 2025 | CBIO GLYCOMIMETICS INC | Award Stock Option (Right to Buy) | 9,023 | - | - | Direct |
| Jun 18, 2025 |  BCAB BioAtla, Inc. | Award | 23,500 | - | - | Direct |
| May 29, 2025 | TYRA Tyra Biosciences, Inc. | Award Stock Option (Right to Buy) | 22,200 | - | - | Direct |
1-5 of 5 transactions